PAYVANDI, FLORA
PAYVANDI, FLORA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Deep Molecular Modeling and Mechanistic Insights into Type 2A VWD with VWF A2 Domain Mutations
2025 O. Seidizadeh, L. Mollica, D. Giana, L. Baronciani, P. Colpani, L. Sicuro, A. Cairo, F. Peyvandi
Genome-wide association study of long COVID
2025 V. Lammi, T. Nakanishi, S.E. Jones, S.J. Andrews, J. Karjalainen, B. Cortes, H.E. O'Brien, A. Ochoa-Guzman, B.E. Fulton-Howard, M. Broberg, H.H. Haapaniemi, M. Kanai, M. Pirinen, A. Schmidt, R.E. Mitchell, A. Mousas, M. Mangino, A. Huerta-Chagoya, N. Sinnott-Armstrong, E.T. Cirulli, M. Vaudel, A.S.F. Kwong, A.K. Maiti, M.M. Marttila, D.C. Posner, A.A. Rodriguez, C. Batini, F. Minnai, A.R. Dearman, C.A.R. Warmerdam, C.B. Sequeros, T.W. Winkler, D.M. Jordan, R. Rescenko, L. Miano, J.M. Lane, R.K. Chung, B. Guillen-Guio, O.C. Leavy, L. Carvajal-Silva, K. Aguilar-Valdes, E. Frangione, L. Guare, E. Vergasova, E. Marouli, P. Striano, U.A. Zainulabid, A. Kumar, H.F. Ahmad, R. Edahiro, S. Azekawa, C. Maj, M.C. Pensel, A. Miller, M.M. Nothen, P. Behzad, S. Schultz, J. Heggemann, D. Balla, D.R. Morrison, V. Mooser, D. Perley, J. Ragoussis, S. Rousseau, F. Shi, G.M. Lathrop, S. Yanishevsky, L. Laurent, D. Auld, M. Bertrand, A. Boisclair, G. Bourque, D. Bujold, M. Durand, D. Adra, J. St-Cyr, M.E.K. Niemi, S.K. Iyengar, T. Cai, K. Cho, S. Sarvadhavabhatla, M.S. Donaire, H. Valenzuela-Jorquera, E. Lamoza, T.V. Arevalo, R. Retamales-Ortega, S. Sanhueza, C.S. Selman, A.X. Silva, T.A. Alarcon, M.F. Martinez, R. Quiroga, P. Zuniga-Pacheco, D. Zapata-Contreras, C.E. Yanez, L.A. Quinones, E.A. Tobar-Calfucoy, V.A. Monardes-Ramirez, I.A. Signore, L.G. Guajardo, A. Figueroa, K.Y. Orostica, C.A. Munoz, M. Fuentes-Guajardo, P. Bocchieri, C. Cabrera, C.A. Echeverria, L.C. Cerpa, G. Donoso, S. Gutierrez-Richards, E. Nova-Lamperti, J.M. Saez Hidalgo, Y. Espinosa-Parrilla, B. Hignell, V. Forgetta, N.R. Harvey, J. Erber, M. Budde, U. Heilbronner, I.-. Larsson, L. Fricke, M. Lipcsey, K. Adorjan, T. Maricic, J.L. Kalman, A. Dinkel, N.S. Mueller, M. Cordioli, U. Protzer, C.D. Spinner, F. Senner, R. Frithiof, E. Wallin, C. Winter, T.G. Schulze, J. Schneider, J. Wiltfang, S. Papiol, C.M. Kripke, A. Verma, M.D. Ritchie, D.J. Rader, L. Trogstad, M. Duran-Gomez, P. Pajukanta, H. Moreno-Macias, S.H.T. Lee, C.A. Aguilar Salinas, G. Castano-Vinyals, M. Kogevinas, X. Farre, A. Carreras, C. Dobano, N. Blay, J. Garcia-Aymerich, A. Blasco, G. Moncunill, S. Iraola-Guzman, R. De Cid, A.L. Guyatt, A.S.B. Mortensen, B. Feenstra, D. Westergaard, S. Brunak, S.R. Ostrowski, N.W. Simons, L.G. Sloofman, A.W. Charney, R.C. Thompson, H. Namkoong, A. Amirsavadkouhi, H.A. Tadi, B. Sharififard, N. Soltani, V. Zarei, R. Aliannejad, E. Ntzani, E. Evangelou, A. Liontos, I. Tzoulaki, H. Milionis, E. Christaki, K.M. Schiabor Barrett, A. Bolze, S. Dabe, I. Neveux, S. White, N.L. Washington, E. Sandoval, F. Tanudjaja, A. Kamelin, V. Ilinsky, D. Kharitonov, A. Kim, N. Plotnikov, L. Shaheen, M. Trofimov, A. Ilinskaya, T. Hannah, F. Colombo, M. Baldassarri, K. Zguro, C. Fallerini, S. Furini, M. Maher, J.M. Cherry, A.C. Burns, R. Saxena, J. Klovins, M. Briviba, P. Raitis, V. Rovite, L.T. Elliott, J. Taher, X. Xinyi, O. Vishnyakova, T.H. Karlsen, F.B.A. Blasi, F. Blandini, A. Bandera, F. Degenhardt, A. Nobili, N. Montano, N. Iannotti, D. Ellinghaus, A. Franke, M. Mantero, G. Lamorte, F. Malvestiti, S. Margarita, A. Muscatello, R. Carpani, F. Peyvandi, D. Prati, L. Ronzoni, M. Tettamanti, A. Kukkonen, S.-. Luoh, C. Erikstrup, O.B.V. Pedersen, J. Lerner-Ellis, A. Colombo, J.J. Grzymski, M. Ishii, Y. Okada, N.D. Beckmann, M. Kumari, R. Wagner, I.M. Heid, C. John, P.J. Short, P. Magnus, L. Ansone, L.V.C. Valenti, S.A. Lee, L.V. Wain, R.A. Verdugo, K. Banasik, F. Geller, L.H. Franke, A. Rakitko, E.L. Duncan, A. Renieri, K.K. Tsilidis, R. De Cid, A. Niavarani, E. Abner, T. Tusie-Luna, S.S. Verma, G.D. Smith, N.J. Timpson, R.K. Madduri, M.J. Daly, A. Ganna, E.C. Schulte, J.B. Richards, K.U. Ludwig, M. Marks-Hultstrom, H. Zeberg, H.M. Ollila
Challenges and considerations of genetic testing in von Willebrand disease
2025 O. Seidizadeh, L. Baronciani, F. Peyvandi
Impact of blood centrifugation on the parameters of thrombin generation assay revisited to look for possible revision of the current guidance
2025 E. Scalambrino, M. Clerici, F. Peyvandi, A. Tripodi
Effect of DNA methylation on inhibitor development in people with hemophilia A treated with FVIII concentrates
2025 H. Chand, S. Hassan, A. Cairo, R. Palla, F. Peyvandi, F. Peyvandi, P.M. Mannucci, I. Garagiola, A. El-Beshlawy, M. Elalfy, V. Ramanan, P. Eshghi, S. Hanagavadi, R. Varadarajan, M. Karimi, M.V. Manglani, C. Ross, G. Young, T. Seth, S. Apte, D.M. Nayak, E. Santagostino, M.E. Mancuso, A.C. Sandoval Gonzalez, J.N. Mahlangu, S. Bonanad Boix, M. Cerqueira, N.P. Ewing, C. Male, T. Owaidah, V. Soto Arellano, N.L. Kobrinsky, S. Majumdar, R.P. Garrido, A. Sachdeva, M. Simpson, M. Thomas, E. Zanon, B. Antmen, K. Kavakli, M.J. Manco-Johnson, M. Martinez, E. Marzouka, M.G. Mazzucconi, D. Neme, A. Palomo Bravo, R. Paredes Aguilera, A. Prezotti, K. Schmitt, B.M. Wicklund, B. Zulfikar, F.R. Rosendaal
Therapeutic plasma exchange-related complications in patients with immune-mediated thrombotic thrombocytopenic purpura: Complications of therapeutic plasma-exchange
2025 P. Agosti, I. Mancini, A. Artoni, C. Cardone, P. De Leo, C. Bichard, A. Truma, B. Ferrari, J.A. Giannotta, N.N. Fantini, M.C. Mocellin, D. Prati, F. Peyvandi
Operationalising a Haemophilia Gene Editing Lexicon for Practical Use
2025 W. Mckeown, C. Hermans, C. Unzu, M.A. Kay, F. Peyvandi, P. Smith, W. Miesbach, G.F. Pierce, K. Khair, L.A. Valentino, S.W. Pipe, M. Pillai, M. Jones, V. Delwart, A. Sindhurakar, D.E. Gutstein, C.M. Kessler
Global prevalence of platelet-type von Willebrand disease
2025 O. Seidizadeh, A. Cairo, M. Othman, F. Peyvandi
Involvement of the contact pathway in COVID-19 coagulopathy
2025 M. Capecchi, C. Novembrino, M. Abbattista, M. Boscolo-Anzoletti, E. Galbiati, S. Griffini, E. Grovetti, L. Valenti, F. Blasi, G. Grasselli, R. Gualtierotti, M. Cugno, F. Peyvandi
Evaluation of different platelet-dependent von Willebrand factor activity assays to assess the in vivo inhibitory effect of caplacizumab on the von Willebrand factor–platelet interaction
2025 P. Colpani, L. Baronciani, I. Mancini, C. Novembrino, A. Lecchi, G. Cozzi, P. De Leo, M.B. Anzoletti, S. La Marca, M. Boscarino, M.T. Pagliari, A. Artoni, F. Peyvandi
Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registry
2025 K. Fischer, R. Lassila, F. Peyvandi, A. Gatt, S.C. Gouw, R. Hollingsworth, T. Lambert, R. Kaczmarek, D.C. Alvarez, M. Makris
Clarifying the role of p.Gln723Lys in hTTP prevalence
2025 O. Seidizadeh, A. Cairo, I. Mancini, J.N. George, F. Peyvandi
Implementing an assay detecting anti-drug antibody against emicizumab: experience from one center in France
2025 C. Auditeau, C. Valsecchi, N.K. Bentounes, A. Le-Goff, A. Harroche, C. Bally, P.J. Lenting, D. Borgel, F. Peyvandi, D. Lasne
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)
2025 P. Coppo, M. Bubenheim, Y. Benhamou, L. Völker, P. Brinkkötter, L. Kühne, P. Knöbl, M.E. Mingot-Castellano, C. Pascual-Izquierdo, J. De La Rubia, J. Del Rio Garma, S. Chaturvedi, C. Masias, M. Mazepa, X.L. Zheng, G. Sinkovits, M. Réti, C.J. Patriquin, K. Pavenski, T. Boechat, J. Farias, E.F. Oliveira Ribeiro, M.L. Lobo De Andrade, A. Veyradier, B. Joly, R. Bouzid, K. Sakai, M. Matsumoto, P. Agosti, I. Mancini, F. Peyvandi, E. Gavriilaki, M. Stubbs, A. Hmaid, S. Cataland, B. Lämmle, M. Scully
Post hoc analysis of bleeding episodes and clinically relevant pharmacokinetic parameters among children <12 years old with severe haemophilia A receiving once-weekly efanesoctocog alfa prophylaxis in the XTEND-Kids phase 3 multinational trial
2025 L. Malec, M. Mathias, A.L. Dunn, B. Nolan, N. Wong, L. Bystrická, U. Khan, G. Neill, E. Santagostino, S. Gunawardena, C. Tarango, F. Peyvandi
AAV Gene Therapy in Severe Hemophilia B
2025 W. Miesbach, F. Peyvandi, G. Pierce
Gene Therapy for Hemophilias: Opportunities and Challenges for the Clinical Laboratory
2025 A. Tripodi, I. Garagiola, N. Bitto, V. La Mura, F. Peyvandi
The genetic spectrum of rare bleeding disorders
2025 S. Mohsenian, O. Seidizadeh, A. Cairo, R. Palla, M. Menegatti, F. Peyvandi
Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidance
2025 B.A. Konkle, F. Peyvandi, G.R. Foster, C. Hermans, V. La Mura, A.D. Leavitt, D. Lillicrap, J. Mahlangu, M.C. Ozelo, S. Pipe, M. Recht, A. Srivastava, G. Young, W. Miesbach
Qualification Criteria of Gene Therapy for Haemophilia-Opinion of the EAHAD Gene Therapy Working Group
2025 W. Miesbach, A. Boban, P. Chowdary, M. Coppens, V. Jimenez-Yuste, R. Klamroth, G. Mulders, M. Crato, F. Peyvandi